{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:50:49Z","timestamp":1772819449981,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RO1-DA040537"],"award-info":[{"award-number":["RO1-DA040537"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RO1-DA037838"],"award-info":[{"award-number":["RO1-DA037838"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RO1-DA042706-A"],"award-info":[{"award-number":["RO1-DA042706-A"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["RO1-DA027049"],"award-info":[{"award-number":["RO1-DA027049"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s13365-017-0538-8","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T15:07:43Z","timestamp":1501513663000},"page":"603-614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2584-3878","authenticated-orcid":false,"given":"Rahul Dev","family":"Jayant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata S. R.","family":"Atluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneham","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudheesh","family":"Pilakka-Kanthikeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajeet","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Yndart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavan","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"538_CR1","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11910-008-0073-3","volume":"8","author":"BM Ances","year":"2008","unstructured":"Ances BM, Clifford DB (2008) HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies. Curr Neurol Neurosci Rep 8:455\u2013461","journal-title":"Curr Neurol Neurosci Rep"},{"key":"538_CR2","doi-asserted-by":"publisher","first-page":"e61399","DOI":"10.1371\/journal.pone.0061399","volume":"8","author":"VS Atluri","year":"2013","unstructured":"Atluri VS, Kanthikeel SP, Reddy PV, Yndart A, Nair MP (2013) Human synaptic plasticity gene expression profile and dendritic spine density changes in HIV-infected human CNS cells: role in HIV-associated neurocognitive disorders (HAND). PLoS One 8:e61399","journal-title":"PLoS One"},{"key":"538_CR3","doi-asserted-by":"publisher","unstructured":"Atluri VSR, Hidalgo M, Samikkannu T, Kurapati KRV, Jayant RD, Sagar V, Nair MP (2015) Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update. Front Cell Neurosci 9:212. doi: 10.3389\/fncel.2015.00212","DOI":"10.3389\/fncel.2015.00212"},{"key":"538_CR4","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.2147\/IJN.S108329","volume":"11","author":"VSR Atluri","year":"2016","unstructured":"Atluri VSR, Jayant RD, Pilakka-Kanthikeel S, Garcia G, Samikkannu T, Yndart A, Kaushik A, Nair M (2016) Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection. Int J Nanomedicine 11:4287","journal-title":"Int J Nanomedicine"},{"key":"538_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11904-012-0134-8","volume":"9","author":"MC Binford","year":"2012","unstructured":"Binford MC, Kahana SY, Altice FL (2012) A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV\/AIDS Reports 9:287\u2013312","journal-title":"Current HIV\/AIDS Reports"},{"key":"538_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archpsyc.58.8.721","volume":"58","author":"EG Bing","year":"2001","unstructured":"Bing EG, Burnam M, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M (2001) Psychiatric disorders and drug use among human immunodeficiency virus infected adults in the united states. Arch gen Psychiatry 58:721\u2013728","journal-title":"Arch gen Psychiatry"},{"key":"538_CR7","doi-asserted-by":"publisher","unstructured":"Borgmann K, Ghorpade A (2015) HIV-1, methamphetamine and astrocytes at neuroinflammatory crossroads. Front Microbiol 6:1143. doi: 10.3389\/fmicb.2015.01143","DOI":"10.3389\/fmicb.2015.01143"},{"key":"538_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2174\/157016212802138823","volume":"10","author":"S Buch","year":"2012","unstructured":"Buch S, Yao H, Guo M, Mori T, Mathias-Costa B, Singh V, Seth P, Wang J, Su T-P (2012) Cocaine and HIV-1 interplay in CNS: cellular and molecular mechanisms. Curr HIV res 10:425","journal-title":"Curr HIV res"},{"key":"538_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","volume":"38","author":"D Ciccarone","year":"2011","unstructured":"Ciccarone D (2011) Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care 38:41\u201358","journal-title":"Prim Care"},{"key":"538_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.ALC.0000113414.73220.21","volume":"28","author":"J Conigliaro","year":"2004","unstructured":"Conigliaro J, Madenwald T, Bryant K, Braithwaite S, Gordon A, Fultz SL, Maisto S, Samet J, Kraemer K, Cook R, Day N, Roach D, Richey S, Justice A (2004) The veterans aging cohort study: observational studies of alcohol use, abuse, and outcomes among human immunodeficiency virus\u2013infected veterans. Alcohol Clin Exp res 28:313\u2013321","journal-title":"Alcohol Clin Exp res"},{"key":"538_CR11","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1126\/science.277.5330.1232","volume":"277","author":"G Decher","year":"1997","unstructured":"Decher G (1997) Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 277:1232\u20131237","journal-title":"Science"},{"key":"538_CR12","doi-asserted-by":"publisher","unstructured":"D\u00edaz L, Mart\u00ednez-Bonet M, S\u00e1nchez J, Fern\u00e1ndez-Pineda A, Jim\u00e9nez JL, Mu\u00f1oz E, Moreno S, \u00c1lvarez S, Mu\u00f1oz-Fern\u00e1ndez M\u00c1 (2015) Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-\u0138B-dependent mechanism. Scientific Reports 5:12442. doi: 10.1038\/srep12442","DOI":"10.1038\/srep12442"},{"key":"538_CR13","doi-asserted-by":"publisher","first-page":"055101","DOI":"10.1088\/0957-4484\/25\/5\/055101","volume":"25","author":"H Ding","year":"2014","unstructured":"Ding H, Sagar V, Agudelo M, Pilakka-Kanthikeel S, Atluri VSR, Raymond A, Samikkannu T, Nair MP (2014) Enhanced blood\u2013brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation. Nanotechnology 25:055101","journal-title":"Nanotechnology"},{"key":"538_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/08964289.2013.866540","volume":"40","author":"R Durvasula","year":"2014","unstructured":"Durvasula R, Miller TR (2014) Substance abuse treatment in persons with HIV\/AIDS: challenges in managing triple diagnosis. Behav med 40:43\u201352","journal-title":"Behav med"},{"key":"538_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neubiorev.2008.01.004","volume":"32","author":"MJ Ferris","year":"2008","unstructured":"Ferris MJ, Mactutus CF, Booze RM (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav rev 32:883\u2013909","journal-title":"Neurosci Biobehav rev"},{"key":"538_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s40429-014-0025-8","volume":"1","author":"BM Gannon","year":"2014","unstructured":"Gannon BM, Reichard EE, Fantegrossi WE (2014) Psychostimulant abuse and HIV infection: cocaine, methamphetamine, and \u2018bath salts\u2019 cathinone analogs. Curr Addict Rep 1:237\u2013242","journal-title":"Curr Addict Rep"},{"key":"538_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2217\/nnm.12.47","volume":"7","author":"PT Hammond","year":"2012","unstructured":"Hammond PT (2012) Polyelectrolyte multilayered nanoparticles: using nanolayers for controlled and targeted systemic release. Nanomedicine 7:619\u2013622","journal-title":"Nanomedicine"},{"key":"538_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","volume":"31","author":"KS Ingersoll","year":"2008","unstructured":"Ingersoll KS, Cohen J (2008) The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav med 31:213\u2013224","journal-title":"J Behav med"},{"key":"538_CR19","unstructured":"Jayant RD, Madhavan N (2016) Materials and methods for sustained release of active compounds. In: US Patent App. 15\/082,611"},{"key":"538_CR20","doi-asserted-by":"publisher","first-page":"00047","DOI":"10.15406\/jnmr.2016.03.00047","volume":"3","author":"R Jayant","year":"2016","unstructured":"Jayant R, Nair M (2016) Nanotechnology for the treatment of NeuroAIDS. J Nanomedicine Res 3:00047","journal-title":"J Nanomedicine Res"},{"key":"538_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1166\/jbn.2007.039","volume":"3","author":"R Jayant","year":"2007","unstructured":"Jayant R, Srivastava R (2007) Dexamethasone release from uniform sized nanoengineered alginate microspheres. J Biomed Nanotechnol 3:245\u2013253","journal-title":"J Biomed Nanotechnol"},{"key":"538_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/10717540903031126","volume":"16","author":"R Jayant","year":"2009","unstructured":"Jayant R, McShane M, Srivastava R (2009) Polyelectrolyte-coated alginate microspheres as drug delivery carriers for dexamethasone release. Drug Delivery 16:331\u2013340","journal-title":"Drug Delivery"},{"key":"538_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijpharm.2010.10.035","volume":"403","author":"RD Jayant","year":"2011","unstructured":"Jayant RD, McShane MJ, Srivastava R (2011) In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression. Int J Pharm 403:268\u2013275","journal-title":"Int J Pharm"},{"key":"538_CR24","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2147\/IJN.S76517","volume":"10","author":"RD Jayant","year":"2015","unstructured":"Jayant RD, Atluri VS, Agudelo M, Sagar V, Kaushik A, Nair M (2015) Sustained-release nanoART formulation for the treatment of neuroAIDS. Int J Nanomedicine 10:1077","journal-title":"Int J Nanomedicine"},{"key":"538_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/13550281003682513","volume":"16","author":"JA Joska","year":"2010","unstructured":"Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ (2010) Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol 16:101\u2013114","journal-title":"J Neurovirol"},{"key":"538_CR26","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1517\/17425247.2014.933803","volume":"11","author":"A Kaushik","year":"2014","unstructured":"Kaushik A, Jayant RD, Sagar V, Nair M (2014) The potential of magneto-electric nanocarriers for drug delivery. Expert Opin Drug Deliv 11:1635\u20131646","journal-title":"Expert Opin Drug Deliv"},{"key":"538_CR27","doi-asserted-by":"publisher","unstructured":"Kaushik A, Jayant RD, Nikkhah-Moshaie R, Bhardwaj V, Roy U, Huang Z, Ruiz A, Yndart A, Atluri V, El-Hage N (2016a) Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers. Sci Rep 6:25309. doi: 10.1038\/srep25309","DOI":"10.1038\/srep25309"},{"key":"538_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bios.2016.06.086","volume":"86","author":"A Kaushik","year":"2016","unstructured":"Kaushik A, Vabbina PK, Atluri V, Shah P, Vashist A, Jayant RD, Yandart A, Nair M (2016b) Electrochemical monitoring-on-chip (E-MoC) of HIV-infection in presence of cocaine and therapeutics. Biosens Bioelectron 86:426\u2013431","journal-title":"Biosens Bioelectron"},{"key":"538_CR29","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.2147\/IJN.S109943","volume":"11","author":"A Kaushik","year":"2016","unstructured":"Kaushik A, Jayant RD, Nair M (2016c) Advancements in nano-enabled therapeutics for neuroHIv management. Int J Nanomedicine 11:4317","journal-title":"Int J Nanomedicine"},{"key":"538_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0740-5472(99)00100-2","volume":"19","author":"JL Kelley","year":"2000","unstructured":"Kelley JL, Petry NM (2000) HIV risk behaviors in male substance abusers with and without antisocial personality disorder. J Subst Abus Treat 19:59\u201366","journal-title":"J Subst Abus Treat"},{"key":"538_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s11481-010-9205-z","volume":"5","author":"KA Lindl","year":"2010","unstructured":"Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL (2010) HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J NeuroImmune Pharmacol 5:294\u2013309","journal-title":"J NeuroImmune Pharmacol"},{"key":"538_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00042560-200107010-00006","volume":"27","author":"GM Lucas","year":"2001","unstructured":"Lucas GM, Cheever LW, Chaisson RE, Moore RD (2001) Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 27:251\u2013259","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"538_CR33","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1080\/09540120412331269585","volume":"16","author":"CL Masson","year":"2004","unstructured":"Masson CL, Sorensen JL, Phibbs CS, Okin RL (2004) Predictors of medical service utilization among individuals with co-occurring HIV infection and substance abuse disorders. AIDS Care 16:744\u2013755","journal-title":"AIDS Care"},{"key":"538_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","volume":"124","author":"T Maurice","year":"2009","unstructured":"Maurice T, Su T-P (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124:195\u2013206","journal-title":"Pharmacol Ther"},{"key":"538_CR35","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/ncomms2717","volume":"4","author":"M Nair","year":"2013","unstructured":"Nair M, Guduru R, Liang P, Hong J, Sagar V, Khizroev S (2013) Externally controlled on-demand release of anti-HIV drug using magneto-electric nanoparticles as carriers. Nat Commun 4:1707","journal-title":"Nat Commun"},{"key":"538_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.addr.2016.02.008","volume":"103","author":"M Nair","year":"2016","unstructured":"Nair M, Jayant RD, Kaushik A, Sagar V (2016) Getting into the brain: potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv rev 103:202\u2013217","journal-title":"Adv Drug Deliv rev"},{"key":"538_CR37","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.2174\/156802611795371323","volume":"11","author":"S Narayanan","year":"2011","unstructured":"Narayanan S, Mesangeau C, Poupaert JH, McCurdy CR (2011) Sigma receptors and cocaine abuse. Curr top med Chem 11:1128\u20131150","journal-title":"Curr top med Chem"},{"key":"538_CR38","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.4049\/jimmunol.158.7.3499","volume":"158","author":"Y Persidsky","year":"1997","unstructured":"Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M (1997) A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158:3499\u20133510","journal-title":"J Immunol"},{"key":"538_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00002030-200401001-00007","volume":"18","author":"J Rabkin","year":"2004","unstructured":"Rabkin J, McElhiney M, Ferrando S (2004) Mood and substance use disorders in older adults with HIV\/AIDS: methodological issues and preliminary evidence. Aids 18:43\u201348","journal-title":"Aids"},{"key":"538_CR40","doi-asserted-by":"publisher","unstructured":"Ramesh G, MacLean AG, Philipp MT (2013) Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediat Inflamm 2013:480739. doi: 10.1155\/2013\/480739","DOI":"10.1155\/2013\/480739"},{"key":"538_CR41","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/jcbfm.2009.112","volume":"29","author":"SH Ramirez","year":"2009","unstructured":"Ramirez SH, Potula R, Fan S, Eidem T, Papugani A, Reichenbach N, Dykstra H, Weksler BB, Romero IA, Couraud PO (2009) Methamphetamine disrupts blood\u2013brain barrier function by induction of oxidative stress in brain endothelial cells. J Cereb Blood Flow Metab 29:1933\u20131945","journal-title":"J Cereb Blood Flow Metab"},{"key":"538_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/13550280903062813","volume":"15","author":"ZM Saiyed","year":"2009","unstructured":"Saiyed ZM, Gandhi NH, Nair MP (2009) AZT 5\u2032-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells. J Neurovirol 15:343\u2013347","journal-title":"J Neurovirol"},{"key":"538_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/1570162X13666150121104720","volume":"12","author":"T Samikkannu","year":"2014","unstructured":"Samikkannu T, SR Atluri V, Arias AY, VK Rao K, Mulet CT, Jayant RD, PN Nair M (2014) HIV-1 subtypes B and C tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders. Curr HIV res 12:397\u2013405","journal-title":"Curr HIV res"},{"key":"538_CR44","doi-asserted-by":"publisher","first-page":"7026","DOI":"10.2174\/138161281940131209142843","volume":"19","author":"WW Stoops","year":"2013","unstructured":"Stoops WW, Rush CR (2013) Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm des 19:7026","journal-title":"Curr Pharm des"},{"key":"538_CR45","first-page":"764","volume":"9","author":"A Tomitaka","year":"2017","unstructured":"Tomitaka A, Arami H, Raymond A, Yndart A, Kaushik A, Jayant RD, Takemura Y, Cai Y, Toborek M, Nair M (2017) Development of magneto-plasmonic nanoparticles for multimodal image-guided therapy to the brain. Nano 9:764\u2013773","journal-title":"Nano"},{"key":"538_CR46","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2011.10.053","volume":"1431","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Shi Y, Qiao L, Sun Y, Ding W, Zhang H, Li N, Chen D (2012) Sigma-1 receptor agonists provide neuroprotection against gp120 via a change in bcl-2 expression in mouse neuronal cultures. Brain res 1431:13\u201322","journal-title":"Brain res"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-017-0538-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-017-0538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-017-0538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T19:38:34Z","timestamp":1692905914000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-017-0538-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1007\/s13365-017-0538-8","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]},"assertion":[{"value":"6 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}